Leo Heyndrickx

Medicine & Life Sciences

1. HIV-1 100%
2. SARS Virus 97%
3. Neutralizing Antibodies 95%
4. Belgium 55%
5. HIV 51%
6. Viruses 50%
7. Vaccines 39%
8. Neutralization Tests 36%
9. GP 140 36%
10. Antibody Formation 34%
11. Guinea-Bissau 33%
12. Reverse Transcriptase Inhibitors 33%
13. Antibodies 31%
14. Anti-Infective Agents 30%
15. Vaccination 27%
16. Immunoglobulin G 27%
17. Mutation 23%
18. Dapivirine 23%
19. Zika Virus 21%
20. Coronavirus nucleocapsid protein 18%
21. Pre-Exposure Prophylaxis 18%
22. Coronavirus Spike Glycoproteins 18%
23. HIV Integrase Inhibitors 17%
24. Simian Immunodeficiency Virus 17%
25. Binding Sites 17%
26. Monoclonal Antibodies 17%
27. Infection 17%
28. Equine infectious anemia virus 16%
29. p31 integrase protein, Human immunodeficiency virus 1 16%
30. Tick-Borne Encephalitis 15%
31. Epitopes 15%
32. Nicotinamide Phosphoribosyltransferase 15%
33. High-Throughput Screening Assays 15%
34. Chikungunya virus 15%
35. Serologic Tests 15%
36. Yellow Fever 15%
37. Proteins 14%
38. Peptide Library 14%
39. Ebolavirus 14%
40. Integrases 13%
41. Severe Acute Respiratory Syndrome 13%
42. Coronavirus 13%
43. Messenger RNA 13%
44. Antigens 13%
45. South America 13%
46. Microcephaly 13%
47. AIDS Vaccines 12%
48. RNA 12%
49. Health Personnel 12%
50. Adipokines 12%